Description

KLAVTIN 625 is a broad-spectrum antibiotic, combining Amoxycillin, a powerful penicillin-class antibacterial, with Clavulanic Acid, a β-lactamase inhibitor. This combination effectively addresses infections caused by resistant bacteria, which might otherwise be difficult to treat with amoxicillin alone. By preventing the degradation of amoxicillin through bacterial enzymes, Clavulanic Acid significantly boosts the efficacy of the antibiotic, making KLAVTIN 625 a preferred choice for combating bacterial infections that would otherwise show resistance to traditional antibiotics.

KLAVTIN 625 is prescribed to treat a wide variety of bacterial infections such as:

• Lower respiratory tract infections including pneumonia and bronchitis.
• ENT infections like sinusitis, tonsillitis, otitis media (middle ear infections).
• Skin and soft tissue infections, including abscesses and cellulitis.
• Bone and joint infections, urinary tract infections, and infections following dental procedures or surgeries.

Additionally, KLAVTIN 625 is formulated to maintain stability in the presence of food, ensuring that its absorption remains optimal even when taken with meals. This improves patient compliance by reducing the occurrence of gastrointestinal disturbances. The combination also reduces the likelihood of developing further bacterial resistance, helping maintain the efficacy of antibiotics for future treatments. Always consult your physician before starting any antibiotic regimen and complete the full course of KLAVTIN 625 to ensure the best therapeutic outcomes.